UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment

PloS one, 2021-10, Vol.16 (10), p.e0258858-e0258858

2021

Volltextzugriff (PDF)

Standardized metrics can reveal region-specific opportunities in community engagement to aid recruitment in HIV prevention trials

PloS one, 2020-09, Vol.15 (9), p.e0239276-e0239276

2020

Volltextzugriff (PDF)

Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody

Journal of acquired immune deficiency syndromes (1999), 2021-05, Vol.87 (1), p.671-679

2021

Volltextzugriff (PDF)

Engaging Transgender People in NIH-Funded HIV/AIDS Clinical Trials Research

Journal of acquired immune deficiency syndromes (1999), 2016-08, Vol.72 Suppl 3 (3), p.S243-S247

2016

Volltextzugriff (PDF)

Stigma, Implicit Bias, and Long-Lasting Prevention Interventions to End the Domestic HIV/AIDS Epidemic

American journal of public health (1971), 2020-01, Vol.110 (1), p.67-68

2020

Volltextzugriff (PDF)

Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

The New England journal of medicine, 2013-11, Vol.369 (22), p.2083-2092

2013

Volltextzugriff (PDF)

A descriptive analysis of transgender participants in phase 1-2a trials of the HIV Vaccine Trials Network (HVTN) in the United States and Peru

Vaccine, 2019-06, Vol.37 (29), p.3911-3917

2019

Volltextzugriff (PDF)

A Demographic Analysis of Racial/Ethnic Minority Enrollment Into HVTN Preventive Early Phase HIV Vaccine Clinical Trials Conducted in the United States, 2002-2016

Public health reports (1974), 2019-01, Vol.134 (1), p.72-80

2019

Volltextzugriff (PDF)

Exploring Barriers and Facilitators to Participation of Male-to-Female Transgender Persons in Preventive HIV Vaccine Clinical Trials

Prevention science, 2014-06, Vol.15 (3), p.268-276

2014

Volltextzugriff (PDF)

Inclusion of Transgender and Gender Non-conforming Communities in Preventive HIV Vaccine Research at the HIV Vaccine Trials Network (HVTN)

AIDS research and human retroviruses, 2014-10, Vol.30 (S1), p.A51-A51

2014

Volltextzugriff (PDF)

Intentions to use preexposure prophylaxis among current phase 2B preventive HIV-1 vaccine efficacy trial participants

Journal of acquired immune deficiency syndromes (1999), 2013-07, Vol.63 (3), p.259-262

2013

Volltextzugriff (PDF)

Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study

EClinicalMedicine, 2023-10, Vol.64, p.102168-102168, Article 102168

2023

Volltextzugriff (PDF)

Transgender Participants in the HIV Vaccine Trial Network's HVTN 505 Trial: A Descriptive and Comparative Analysis

AIDS research and human retroviruses, 2014-10, Vol.30 (S1), p.A189-A189

2014

Volltextzugriff (PDF)

Implementing Good Participatory Practice (GPP) in HVTN505 - The HIV Vaccine Trials Network (HVTN) Experience

AIDS research and human retroviruses, 2014-10, Vol.30 (S1), p.A105-A106

2014

Volltextzugriff (PDF)

Testing the waters: Ethical considerations for including PrEP in a phase IIb HIV vaccine efficacy trial

Clinical trials (London, England), 2015-08, Vol.12 (4), p.394-402

2015

Volltextzugriff (PDF)

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)

Open forum infectious diseases, 2015-09, Vol.2 (3), p.ofv082

2015

Volltextzugriff (PDF)

American Society of Clinical Oncology Clinical practice guidelines for the use of chemotherapy and radiotherapy protectants

Journal of clinical oncology, 1999-10, Vol.17 (10), p.3333-3355

1999

Volltextzugriff (PDF)

American Society of Clinical Oncology Clinical Practice Guidelinesfor the Use of Chemotherapy and Radiotherapy Protectants

Journal of clinical oncology, 1999-10, Vol.17 (10), p.3333-3355

1999

Volltextzugriff (PDF)

Standardized metrics can reveal region-specific opportunities in community engagement to aid recruitment in HIV prevention trials

PloS one, 2020-01, Vol.15 (9), p.e0239276

2020

Volltextzugriff (PDF)

Feline Model of Acute Nipah Virus Infection and Protection with a Soluble Glycoprotein-Based Subunit Vaccine

Journal of Virology, 2006-12, Vol.80 (24), p.12293-12302

2006

Volltextzugriff (PDF)

Projections of the Incidence of Non-Hodgkin's Lymphoma Related to Acquired Immunodeficiency Syndrome

JNCI : Journal of the National Cancer Institute, 1991-05, Vol.83 (10), p.695-701

1991

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(14)
Humans
(12)
Hiv
(11)
Human Immunodeficiency Virus
(11)
Adult
(10)
Male
(10)
Female
(9)
Hiv Infections - Prevention & Control
(9)
Vaccines
(9)
Clinical Trials
(8)
Disease Prevention
(8)
Middle Aged
(8)
Infectious Diseases
(7)
Transgender Persons
(7)
Adolescent
(6)
Biological And Medical Sciences
(6)
Prevention
(6)
Immunology
(5)
Medical Research
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment

Standardized metrics can reveal region-specific opportunities in community engagement to aid recruitment in HIV prevention trials

Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody

Engaging Transgender People in NIH-Funded HIV/AIDS Clinical Trials Research

Stigma, Implicit Bias, and Long-Lasting Prevention Interventions to End the Domestic HIV/AIDS Epidemic

Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

A descriptive analysis of transgender participants in phase 1-2a trials of the HIV Vaccine Trials Network (HVTN) in the United States and Peru

A Demographic Analysis of Racial/Ethnic Minority Enrollment Into HVTN Preventive Early Phase HIV Vaccine Clinical Trials Conducted in the United States, 2002-2016

Exploring Barriers and Facilitators to Participation of Male-to-Female Transgender Persons in Preventive HIV Vaccine Clinical Trials

Inclusion of Transgender and Gender Non-conforming Communities in Preventive HIV Vaccine Research at the HIV Vaccine Trials Network (HVTN)

Intentions to use preexposure prophylaxis among current phase 2B preventive HIV-1 vaccine efficacy trial participants

Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study

Transgender Participants in the HIV Vaccine Trial Network's HVTN 505 Trial: A Descriptive and Comparative Analysis

Implementing Good Participatory Practice (GPP) in HVTN505 - The HIV Vaccine Trials Network (HVTN) Experience

Testing the waters: Ethical considerations for including PrEP in a phase IIb HIV vaccine efficacy trial

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)

American Society of Clinical Oncology Clinical practice guidelines for the use of chemotherapy and radiotherapy protectants

American Society of Clinical Oncology Clinical Practice Guidelinesfor the Use of Chemotherapy and Radiotherapy Protectants

Standardized metrics can reveal region-specific opportunities in community engagement to aid recruitment in HIV prevention trials

Feline Model of Acute Nipah Virus Infection and Protection with a Soluble Glycoprotein-Based Subunit Vaccine

Projections of the Incidence of Non-Hodgkin's Lymphoma Related to Acquired Immunodeficiency Syndrome

Suchergebnisse filtern